Literature DB >> 19020833

Methods to study monocyte migration induced by HIV-infected cells.

Vasudev R Rao1, Eliseo A Eugenin, Joan W Berman, Vinayaka R Prasad.   

Abstract

HIV-associated dementia (HAD) is a multi-factorial disease set in motion by the presence of HIV-infected cells in the brain. A characteristic feature of HAD is the infiltration of mononuclear phagocytes into the brain, which is aided by HIV-1 Tat protein and other chemokines secreted by both HIV-infected cells and uninfected cells in their vicinity. Both direct and indirect chemokine activity of HIV-1 Tat protein has been demonstrated employing purified recombinant Tat protein. However, a corroboration of a key role for Tat or other chemokines in monocyte migration, in the context of HIV-infection, has not yet been demonstrated. Here we describe methods, to measure the role of soluble factors, such as chemokines and Tat, released by HIV-infected cells or uninfected cells in their vicinity, in monocyte migration in vitro.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19020833      PMCID: PMC4350668          DOI: 10.1007/978-1-59745-170-3_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons.

Authors:  R Bonavia; A Bajetto; S Barbero; A Albini; D M Noonan; G Schettini
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

2.  Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  Gregory J Dore; Ann McDonald; Yueming Li; John M Kaldor; Bruce J Brew
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

Review 3.  Neurologic consequences of HIV infection in the era of HAART.

Authors:  Kirk Sperber; Ling Shao
Journal:  AIDS Patient Care STDS       Date:  2003-10       Impact factor: 5.078

4.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

5.  Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor.

Authors:  Mark A Prendergast; D Trent Rogers; Patrick J Mulholland; John M Littleton; Lincoln H Wilkins; Rachel L Self; Avindra Nath
Journal:  Brain Res       Date:  2002-11-08       Impact factor: 3.252

Review 6.  Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex.

Authors:  H S Nottet; H E Gendelman
Journal:  Immunol Today       Date:  1995-09

7.  Expression of HIV regulatory and structural mRNA in the central nervous system.

Authors:  C A Wiley; M Baldwin; C L Achim
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

8.  Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.

Authors:  B Ensoli; L Buonaguro; G Barillari; V Fiorelli; R Gendelman; R A Morgan; P Wingfield; R C Gallo
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.

Authors:  Eliseo A Eugenin; Jessie E King; Avindra Nath; Tina M Calderon; R Suzanne Zukin; Michael V L Bennett; Joan W Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

View more
  4 in total

1.  HIV-1 clade-specific differences in the induction of neuropathogenesis.

Authors:  Vasudev R Rao; Andrew R Sas; Eliseo A Eugenin; Nagadenahalli B Siddappa; Heather Bimonte-Nelson; Joan W Berman; Udaykumar Ranga; William R Tyor; Vinayaka R Prasad
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

2.  The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates.

Authors:  Vasudev R Rao; Ujjwal Neogi; Eliseo Eugenin; Vinayaka R Prasad
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

3.  Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals.

Authors:  Dina Tsukrov; Alicia McFarren; Alfred Morgenstern; Frank Bruchertseifer; Eugene Dolce; Miroslaw K Gorny; Susan Zolla-Pazner; Joan W Berman; Ellie Schoenbaum; Barry S Zingman; Arturo Casadevall; Ekaterina Dadachova
Journal:  Front Med (Lausanne)       Date:  2016-09-26

4.  Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.

Authors:  Vasudev R Rao; Ujjwal Neogi; Joshua S Talboom; Ligia Padilla; Mustafizur Rahman; Cari Fritz-French; Sandra Gonzalez-Ramirez; Anjali Verma; Charles Wood; Ruth M Ruprecht; Udaykumar Ranga; Tasnim Azim; John Joska; Eliseo Eugenin; Anita Shet; Heather Bimonte-Nelson; William R Tyor; Vinayaka R Prasad
Journal:  Retrovirology       Date:  2013-06-08       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.